Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.90)
# 3,905
Out of 4,983 analysts
323
Total ratings
26.69%
Success rate
-27.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGEN Agenus | Reiterates: Buy | $23 | $4.47 | +414.54% | 20 | Sep 10, 2025 | |
| AGIO Agios Pharmaceuticals | Reiterates: Buy | $56 | $36.72 | +52.51% | 2 | Sep 4, 2025 | |
| BCTX BriaCell Therapeutics | Maintains: Buy | $32 → $40 | $8.21 | +387.21% | 15 | Aug 27, 2025 | |
| INKT MiNK Therapeutics | Upgrades: Buy | $35 | $14.59 | +139.89% | 14 | Aug 15, 2025 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $36 | $21.18 | +70.01% | 2 | Aug 13, 2025 | |
| FEMY Femasys | Maintains: Buy | $12 → $8 | $0.37 | +2,062.16% | 25 | Aug 11, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $5 → $4 | $0.85 | +371.81% | 12 | Aug 7, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $10 → $9 | $2.15 | +318.60% | 2 | Jul 22, 2025 | |
| RAPT RAPT Therapeutics | Maintains: Buy | $6 → $27 | $17.63 | +53.15% | 2 | Jul 10, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Buy | $40 → $20 | $2.43 | +723.05% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $5.67 | +535.48% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $77.35 | +48.67% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $12 | $2.37 | +406.33% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $38 | $19.39 | +95.98% | 10 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.89 | +280.23% | 20 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.10 | +254.84% | 11 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $11.67 | +2,299.31% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.61 | +396.89% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.72 | +597.67% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.09 | +633.50% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.55 | +1,125.81% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.95 | +823.08% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $5.42 | +3,269.19% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.82 | +751.58% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.25 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $11.75 | +104.26% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.26 | +1,328.57% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.34 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $12.68 | +199.68% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.60 | +5,375.36% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.10 | - | 1 | Apr 25, 2024 |
Agenus
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $4.47
Upside: +414.54%
Agios Pharmaceuticals
Sep 4, 2025
Reiterates: Buy
Price Target: $56
Current: $36.72
Upside: +52.51%
BriaCell Therapeutics
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $8.21
Upside: +387.21%
MiNK Therapeutics
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $14.59
Upside: +139.89%
vTv Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $21.18
Upside: +70.01%
Femasys
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.37
Upside: +2,062.16%
Context Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.85
Upside: +371.81%
SAB Biotherapeutics
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.15
Upside: +318.60%
RAPT Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $6 → $27
Current: $17.63
Upside: +53.15%
Jasper Therapeutics
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $2.43
Upside: +723.05%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $5.67
Upside: +535.48%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $77.35
Upside: +48.67%
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.37
Upside: +406.33%
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $19.39
Upside: +95.98%
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $7.89
Upside: +280.23%
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $3.10
Upside: +254.84%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $11.67
Upside: +2,299.31%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $1.61
Upside: +396.89%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $1.72
Upside: +597.67%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.09
Upside: +633.50%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.55
Upside: +1,125.81%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.95
Upside: +823.08%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $5.42
Upside: +3,269.19%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.82
Upside: +751.58%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.25
Upside: -
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $11.75
Upside: +104.26%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.26
Upside: +1,328.57%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.34
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $12.68
Upside: +199.68%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.60
Upside: +5,375.36%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.10
Upside: -